Liang, H.; Lykins, W.R.; Seydoux, E.; Guderian, J.A.; Phan, T.; Fox, C.B.; Orr, M.T.
Formulated Phospholipids as Non-Canonical TLR4 Agonists. Pharmaceutics 2022, 14, 2557.
https://doi.org/10.3390/pharmaceutics14122557
AMA Style
Liang H, Lykins WR, Seydoux E, Guderian JA, Phan T, Fox CB, Orr MT.
Formulated Phospholipids as Non-Canonical TLR4 Agonists. Pharmaceutics. 2022; 14(12):2557.
https://doi.org/10.3390/pharmaceutics14122557
Chicago/Turabian Style
Liang, Hong, William R. Lykins, Emilie Seydoux, Jeffrey A. Guderian, Tony Phan, Christopher B. Fox, and Mark T. Orr.
2022. "Formulated Phospholipids as Non-Canonical TLR4 Agonists" Pharmaceutics 14, no. 12: 2557.
https://doi.org/10.3390/pharmaceutics14122557
APA Style
Liang, H., Lykins, W. R., Seydoux, E., Guderian, J. A., Phan, T., Fox, C. B., & Orr, M. T.
(2022). Formulated Phospholipids as Non-Canonical TLR4 Agonists. Pharmaceutics, 14(12), 2557.
https://doi.org/10.3390/pharmaceutics14122557